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Purpose: Deep brain stimulation (DBS) of the subthalamic nucleus (STN)
is an indispensable and effective surgery for patients with primary
Parkinson’s disease (PD). Nonetheless, its postoperative effects can be
decided by many factors including the optimal programmed stimulation
parameters. In this study, we analyzed the correlation between different
postoperative programmed stimulation parameters and their efficacy
after STN–DBS electrode implantation in patients with PD.
Methods: A total of 87 patients underwent electrode implantation and
completed at least one year follow-up. Then, various combinations of
stimulation parameters, including stimulus intensity, frequency, and pulse
width, were examined for their effects on the clinical improvement of the
patients. Improvements in motor and nonmotor symptoms were analyzed
using Mini-Mental State Examination, Parkinson’s Disease Quality of Life
Questionnaire-39, and Unified Parkinson’s Disease Rating Scale (UPDRS)
scores before and after surgery.
Results: We found significantly improved UPDRS scores, quality of life,
and neuropsychiatric symptoms postoperatively considering the findings
of the aforementioned stimulation parameters compared with those
observed preoperatively.
Conclusion: This study provides a better understanding on how programmed stimulation parameters help relieve PD symptoms and improve
quality of life in patients with PD undergoing STN–DBS.
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is published with open access at
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Introduction

Parkinson’s disease (PD), the second largest
degenerative disease of the central nervous system
in China, is common among elderly individuals.
Its main clinical manifestations include resting
Corresponding author: Yujun Hao, E-mail: hyj620530@vip.sohu.com

tremors, muscle stiffness, motor retardation, and
postural instability [1, 2]. Deep brain stimulation
(DBS) has been widely accepted as an efficient
surgical approach since its first application in
China approximately 20 years ago [3, 4]. Its
minimally invasive, reversible, and adjustable
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characteristics make it an indispensable option.
Several clinical and experimental studies have
demonstrated that DBS of the subthalamic nucleus
(STN) can effectively control resting tremors,
muscle stiffness, bradykinesia, and dyskinesia in
individuals with PD [5]. However, its curative
effects have been associated with alternative
programmed stimulus intensity, frequency, and
pulse width. Therefore, we examined various
combinations of altering stimulation parameters
to determine the correlation between programmed
stimulation parameters and their efficacy after
DBS electrode implantation for PD.

2
2.1

Methods
Patients

We recruited a total of 87 patients with PD based
on Movement Disorder Society Clinical Diagnostic
Criteria for Parkinson’s Disease, including 61 males
(average age, 61 years; 70%) and 26 females
(average age, 64 years; 30%), who underwent
electrode implantation by our neurosurgical
functional group at the First Affiliated Hospital
of Xinjiang Medical University from 2012 to
2018 (Table 1). All patients were preoperatively
informed about the benefits and risks of the
surgery. All patients signed an informed consent
form, and all procedures were approved by the
institutional ethics committee.
The selection criteria were as follows: (1)
diagnosis of PD, (2) fit for STN–DBS, (3) responsive

to Madopar, (4) course of illness > 4 years, and
(5) age ≤ 75 years.
The exclusion criteria were as follows: (1) severe
cognitive dysfunction due to mental illness,
(2) other comorbidities that significantly increase
mortality risk, (3) any neuro comorbidities that
may interfere with symptoms.
2.2

Surgical procedure

All the patients were preoperatively examined
using computed tomography (CT) and magnetic
resonance imaging (MRI). Then, the patients
underwent stereotactic frame installation under
local anesthesia during head CT. By fusing CT
and MRI images, we determined the precise
functional localization of the target coordinates
and nucleus using a microelectrode recording
system. The positioning of the final implant
electrode was determined according to the data
acquired for the electrodischarge characteristics
of the neurons and needle length. A temporary
pulse generator was used for prestimulation.
Postoperative CT was used to confirm whether
the electrodes were located at both sides of STN.
2.3

Study design

All included patients were followed up for 12
months. To explore the effects of different
combinations of stimulation parameters on the
main motor symptoms of PD, we altered frequency,
voltage/current, pulse width, and amplitude
during follow-up, after which patients’ symptoms

Table 1 Baseline demographic and clinical characteristics of the included patients with Parkinson’s disease (n = 87).
Baseline characteristics

Description or mean (± standard deviation)

Age (years)

62 (± 9.6)

Sex

61 males, 21 females

Cardinal symptom

Resting tremors, muscle stiffness, and bradykinesia

Duration of deep brain stimulation (years)

5 (± 2.3)

L-dopa-equivalent daily dose (mg)

540 (± 257)

Course of illness (years)

4 (± 3.2)
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including resting tremors, muscle stiffness, and
motor retardation were assessed. Accordingly,
one parameter was used as a variable, whereas
the other two parameters were kept constant. All
programmed procedures performed on a patient
lasted for ≤ 4 h in the morning. All preoperative
and postoperative assessments were performed
using objective scales.
2.4

Statistical analysis

Descriptive statistics were used to describe the
patients’ general information as well as preoperative and postoperative indices. All data were
quantitative, and statistical significance was set at
p < 0.05. During follow-up, scores were analyzed
using variance analysis and compared using a
randomized group design. Statistical analysis was
performed using SPSS (version 23.0).

3

Results

Pulse width and frequency were uniformly
set at 60–120 μs and 130–185 Hz, respectively.
Postoperative stimulation voltage was set at
1.0 ± 1.0 V in 38 cases, 2.5 ± 1.0 V in 32 cases at
postoperative 6 months, and at 3.0 ± 1.0 V in 17
cases at postoperative 24 months (Table 2). Until
December, 2018, stimulation was performed in 48
cases involving single negative contact, whereas
20 cases involving total negative stimulation
which also included cases of double negative

stimulation. The remaining cases included crosselectric pulse, frequency conversion stimulation,
and inter-frequency stimulation. No severe surgical
complications such as intracranial hematoma
and electrode fracture were observed in any of the
cases. Moreover, 2 patients exhibited improvement
in short-term nonmotor symptoms owing to
voltage lowering and stimulation site adjustment
[6]. Four patients had obvious dyskinesia preoperatively, whereas single negative stimulation
did not significantly improve their symptoms after
the operation. However, dyskinesia was clearly
controlled after double negative stimulation and
voltage lowering. Three patients had difficulty
in blinking following electrode implantation.
After adjusting the stimulation parameters, all
patients were followed up through telephone,
E-mail, or clinic visitation, with one patient having
been lost to follow-up at postoperative 6 months
(Table 3).

4

Discussion

PD is a common occult neurodegenerative
disorder characterized by resting tremors, muscle
stiffness, or bradykinesia, which remains incurable
to date. Although L-dopa can improve the
symptoms of PD, its use is limited by patients’
responsiveness to the drug and the length of the
“honeymoon” period, which limits its long-term
use [7]. Since the 1980s, DBS and other related

Table 2 Deep brain stimulation parameters.
DBS parameters

Right STN

Left STN

Start-up

6 months

12 months

Voltage (V)

1.0 ± 0.90

2.6 ± 0.90

3.0 ± 0.90

Pulse width (μs)

60

60 ± 15.50

90 ± 15.0

Frequency (Hz)

125 ± 27.50

138 ± 27.50

140 ± 27.50

Voltage (V)

1.0 ± 1.1

2.5 ± 1.1

3.0 ± 1.1

Pulse width (μs)

60

60 ± 16.60

90 ± 16.60

Frequency (Hz)

125 ± 28.50

140 ± 28.50

150 ± 28.50

DBS, deep brain stimulation; STN, subthalamic nucleus.
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Table 3 Efficacy scores after deep brain stimulation.
Preoperative

After booting

Postoperative
6 months

Postoperative 12 months

MMSE

23.0 ± 2.39

22.1 ± 2.36

21.2 ± 3.10

23.0 ± 2.50

UPDRS-I

3.25 ± 3.53

2.37 ± 3.07

2.10 ± 2.30

2.21 ± 3.02

UPDRS-II

20.5 ± 10.2

8.75 ± 11.0*

7.20 ± 12.3*

7.0 ± 11.5*

UPDRS-III

47.12 ± 9.0

23.7 ± 10.4*

18.6 ± 10.7*

20.7 ± 11.4

PDQ-39

90.5 ± 3.0

58.0 ± 7.50*

55.0 ± 7.0*

54.2 ± 7.8*

*, p < 0.05 compared with the preoperative scores, respectively. MMSE, Mini-Mental State Examination; UPDRS, Unified
Parkinson’s Disease Rating Scale; PDQ-39, Parkinson’s Disease Questionnaire.

technologies have been developed vigorously,
among which STN–DBS has been used most
widely. Compared with other approaches, STN–
DBS has the advantage of including a clear target,
which can directly stimulate STN and block
abnormal neural circuits. The mechanism by
which STN–DBS exerts curative effects remains
unclear. Nonetheless, the key factors in DBS
treatment have been accurately implanting
stimulus electrodes and obtaining the optimal
curative effect with minimum voltage [8]. The
optimal clinical efficacy can be obtained by
stimulating the conductive fibers present around
STN with minimum electricity. STN–DBS can
improve the quality of life of patients with PD
while reducing the use of L-dopa [9].
In this study, all 87 patients were followed up
through long-term programmed control. Among
them, 5 patients underwent electrode implantation
at a voltage of > 5 V and 1 at a voltage of < 2 V.
We observed improvement in motor symptoms
in the patients who underwent electrode implantation within a certain range of voltage as
well as at the same site, frequency, and pulse
width. At a voltage of > 4 V, resting tremors and
muscle stiffness could still be improved with
increasing voltage; however, the side effects
of high voltage became more apparent than its
benefits. Ultimately, the effects of programmed
control were considered unsatisfactory. Studies
showed that a number of patients suffered from

axial symptoms and freezing of gait (FOG), which
significantly affected their quality of life [10].
Accordingly, these symptoms could be improved
by adjusting other stimulation parameters. The
present study included 1 case wherein the use of
high-voltage implantation proved inappropriate.
Although the results of multiple programmed
control were unsatisfactory, continuous current
stimulation was used to improve limb stiffness
after measuring impedance. Although many
studies showed no statistical difference in varied
voltage or current for PD improvement [11],
continuous current stimulation may be a better
choice for patients with high impedance.
Overall, the present studies showed that low
frequency was helpful in improving FOG and
axial impairment [12–14]. During our follow-up,
10 patients exhibited acute FOG symptoms.
Among them, 4 patients showed improvement
after choosing a site at the back of the STN
as the contact position, lowering frequency, and
increasing voltage, whereas 3 showed improvement after setting multiple stimulation. Although
lowering the frequency of stimulation (from 130
to 60 Hz) significantly improved FOG in 1 patient,
the effect of programmed control rapidly decreased
after only 24 h. Thus, this step may not be
appropriate for patients with postoperative FOG
given that it could lead to the reappearance of
resting tremors and muscle stiffness.
In programmed control, pulse width had rarely
Journal of Neurorestoratology
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been adjusted and often remained between 60
and 90 μs. Although recent studies have shown
that a narrow pulse width could reduce side
effects within the effective treatment window
[15–17], our examination showed no obvious
difference in effect between a pulse width of > 90
and < 60 μs. Accordingly, despite using a narrow
pulse width and low voltage in 2 patients, no
effective symptom improvement was observed,
unlike when a specific pulse width was used.
Thus, more evidence-based research may be
needed for the selection of a narrow pulse width.
DBS, which is characterized as minimally
invasive, reversible, and adjustable, has been a
well-accepted surgical treatment for dyskinesia,
with postoperative programmed control being
an indispensable part [1, 3, 18]. Electrode
implantation was initiated at postoperative 1
month to reduce injury and stabilize electrode
impedance, during which the patients’ condition
can be considered good. The initiation of
programmed control should be performed at the
off medication state to accurately observe the
stimulation effect. Most initial parameters used
herein were set to be a pulse width of 60 μs and
frequency of 130 Hz. Further, voltage was adjusted
according to the patient’s reaction. In theory,
motor symptoms could be better improved when
voltage is set at 2–3 V, and the therapeutic
effect was gradually strengthened by increasing
it. Nonetheless, no obvious difference was observed
in efficacy between voltage of 2 and 3 V. In
addition, stimulation frequency ranging from 130
to 180 Hz was found to improve FOG. Although
increasing the stimulation pulse width could
improve symptoms, changes in pulse width
were not as beneficial as those in voltage and
frequency.
Several problems could be resolved immediately
when a patient seeks programmed control again.
However, gait dysfunction and FOG as well as
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other issues need to be programmed repeatedly.
With a prolonged course of illness, patients would
also need programmed control due to nonmotor
symptoms. For example, dyskinesia, an adverse
reaction that often occurs after SNT–DBS, can be
ameliorated by reducing voltage, dopamine use,
and setting double negative stimulation. Moreover,
autism involved uncontrollable blinking, a form
of dystonia, can be improved by increasing the
amount of dopamine, reducing the frequency of
voltage regulation and pulse width, and changing
the backside contact position.
Given that postoperative programmed control
is a long-term and cumbersome dynamic process,
this prospective study included patients who
underwent bilateral STN–DBS from 2012 to 2018.
Accordingly, we found that a single increase in
voltage during programmed control does not
effectively improve motor symptoms but may
often cause stimulation-related complications
such as dysarthria. STN–DBS has generally been
considered a safe and effective treatment for PD;
further, it reduces the dosage and side effects
of the drugs used. Moreover, postoperative
programmed control is an integral part of DBS.

Conflict of interests
All contributing authors have no conflict of
interests related to this work.

Acknowledgements
This work is funded by Autonomous Region
Natural Fund.

References
[1] Muthuraman M, Deuschl G, Koirala N, et al. Effects
of DBS in parkinsonian patients depend on the
structural integrity of frontal cortex. Sci Rep. 2017, 7:
43571.

Journal of Neurorestoratology

58
[2] Hess CW, Hallett M. The phenomenology of
Parkinson’s disease. Semin Neurol. 2017, 37(2):
109–117.
[3] Graat I, Figee M, Denys D. The application of deep
brain stimulation in the treatment of psychiatric
disorders. Int Rev Psychiatry. 2017, 29(2): 178–190.
[4] Parpaley Y, Skodda S. Deep brain stimulation in
movement disorders: evidence and therapy standards.
Fortschr Neurol Psychiatr. 2017, 85(7): 414–431.
[5] Mideksa KG, Singh A, Hoogenboom N, et al. Comparison of imaging modalities and source-localization
algorithms in locating the induced activity during deep
brain stimulation of the STN. Conf Proc IEEE Eng
Med Biol Soc. 2016, 2016: 105–108.
[6] Dayal V, Limousin P, Foltynie T. Subthalamic nucleus
deep brain stimulation in Parkinson’s disease: the
effect of varying stimulation parameters. J Parkinsons
Dis. 2017, 7(2): 235–245.
[7] Hand A, Gray WK, Oates LL, et al. Medication use
in people with late stage Parkinson’s disease and
parkinsonism living at home and in institutional care
in North-East England: A balance of symptoms and
side-effects? Parkinsonism Relat Disord. 2016, 32:
120–123.
[8] Bari AA, Fasano A, Munhoz RP, et al. Improving
outcomes of subthalamic nucleus deep brain stimulation
in Parkinson’s disease. Expert Rev Neurother. 2015,
15(10): 1151–1160.
[9] Kobayashi M, Ohira T, Mihara B, et al. Changes in
intracortical inhibition and clinical symptoms after
STN-DBS in Parkinson’s disease. Clin Neurophysiol.
2016, 127(4): 2031–2037.
[10] Huang CY, Chu HL, Zhang Y, et al. Deep brain
stimulation to alleviate freezing of gait and cognitive
dysfunction in Parkinson's disease: update on current
research and future perspectives. Front Neurosci.

2018, 12: 29.
[11] Amami P, Mascia MM, Franzini A, et al. Shifting
from constant-voltage to constant-current in Parkinson’s
disease patients with chronic stimulation. Neurol Sci.
2017, 38(8): 1505–1508.
[12] Vallabhajosula S, Haq IU, Hwynn N, et al. Lowfrequency versus high-frequency subthalamic nucleus
deep brain stimulation on postural control and gait
in Parkinson’s disease: a quantitative study. Brain
Stimul. 2015, 8(1): 64–75.
[13] Zibetti M, Moro E, Krishna V, et al. Low-frequency
subthalamic stimulation in Parkinson’s disease: longterm outcome and predictors. Brain Stimul. 2016,
9(5): 774–779.
[14] Whitmer D, de Solages C, Hill B, et al. High frequency
deep brain stimulation attenuates subthalamic and
cortical rhythms in Parkinson’s disease. Front Hum
Neurosci. 2012, 6: 155.
[15] Dayal V, Grover T, Limousin P, et al. The effect of
short pulse width settings on the therapeutic window
in subthalamic nucleus deep brain stimulation for
Parkinson’s disease. J Parkinsons Dis. 2018, 8(2):
273–279.
[16] Bouthour W, Wegrzyk J, Momjian S, et al. Short
pulse width in subthalamic stimulation in Parkinson’s
disease: a randomized, double-blind study. Mov Disord.
2018, 33(1): 169–173.
[17] Steigerwald F, Timmermann L, Kühn A, et al. Pulse
duration settings in subthalamic stimulation for
Parkinson’s disease. Mov Disord. 2018, 33(1): 165–169.
[18] Khojandi A, Shylo O, Mannini L, et al. Stratifying
Parkinson’s patients with STN-DBS into highfrequency or 60 hz-frequency modulation using a
computational model. Neuromodulation. 2017, 20(5):
450–455.

Jingchao Lu, M.D., affiliated to the First Affiliated Hospital of Xinjiang Medical
University. He focuses on the clinical diagnosis and treatment of intractable epilepsy
and Parkinson’s disease as well as related genetic research and functional
neurosurgery. E-mail: Ljc1630302@126.com

Journal of Neurorestoratology

Journal of Neurorestoratology

59

Zhaohai Feng, M.D., affiliated to the Functional Neurosurgery Department in the
First Affiliated Hospital of Xinjiang Medical University. He focuses on the clinical
diagnosis and treatment of intractable epilepsy, pain, neuromuscular diseases,
Parkinson’s disease, neurogenetic diseases, and neurodegenerative diseases as well
as related genetic research. E-mail: 15199115545@163.com

Xin Shi, Ph.D., affiliated to the Functional Neurosurgery Department in the First
Affiliated Hospital of Xinjiang Medical University. He has a solid foundation in the
diagnosis and treatment of common neurosurgical diseases, extensive experience in
the diagnosis and treatment of difficult and severe neurosurgical diseases, and
in-depth knowledge on functional neurosurgery. E-mail: Shixin6605@126.com

Yujun Hao, M.D., affiliated to the Functional Neurosurgery Department in the
First Affiliated Hospital of Xinjiang Medical University. He focuses on the study
of microvascular decompression for the treatment of facial spasms, trigeminal
neuralgia, glossopharyngeal neuralgia, and other cranial nerve disorders. He is also
occupied in surgery and clinical research of epilepsy and nerve-related pain disorders.
E-mail: hyj620530@vip.sohu.com

